Market Research Logo

Global Scleroderma Treatment Market 2017-2021

Global Scleroderma Treatment Market 2017-2021

About Scleroderma Treatment

Scleroderma is an autoimmune disorder, which is a condition when body’s tissues get attacked by the immune system. The term scleroderma is defined as the hardening of the skin; however, it is much more than the skin disorder. The disease is characterized by microvascular injury and fibrosis in the affected organs.

Technavio’s analysts forecast the global scleroderma treatment market to grow at a CAGR of 7.02% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global scleroderma treatment market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Scleroderma Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AstraZeneca
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Pfizer
Other prominent vendors
  • Amgen
  • Bayer AG
  • Boehringer Ingelheim
  • Biogen
  • CELGENE
  • Corbus Pharmaceuticals
  • Johnson & Johnson
  • Merck
  • Novartis
  • Sanofi
Market driver
  • High unmet medical needs
  • For a full, detailed list, view our report
Market challenge
  • Unknown pathogenesis of the disorder
  • For a full, detailed list, view our report
Market trend
  • Partnerships and strategic alliances
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
    • Scleroderma disease overview
      • Table Types of scleroderma
  • Market landscape
    • Market overview
      • Table Global scleroderma treatment market snapshot
      • Table Global scleroderma treatment market 2016-2021 ($ millions)
      • Table Opportunity analysis in global scleroderma treatment market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Number of pipeline molecules by vendors at various phases
    • Table Key clinical trials
  • Market segmentation by drug class
    • Table Global scleroderma treatment market by drug class
    • Anti-inflammatory drugs
      • Table Side effects associated with anti-inflammatory drug class
      • Table Global scleroderma anti-inflammatory drugs market 2016-2021 ($ millions)
      • Table Drivers and challenges of anti-inflammatory drugs
    • Immunosuppressants
      • Table Side effects associated with immunosuppressants
      • Table Global scleroderma immunosuppressants market 2016-2021 ($ millions)
      • Table Drivers and challenges of immunosuppressants
    • Others
      • Table Global scleroderma treatment market by others drug class 2016-2021 ($ millions)
      • Table Major drug classes included in the others segment
    • PDE5 inhibitors
      • Table Side effects associated with PDE5 inhibitors
      • Table Global scleroderma PDE5 inhibitors market 2016-2021 ($ millions)
      • Table Drivers and challenges of PDE5 inhibitors
    • Calcium channel blockers
      • Table Side effects associated with calcium channel blockers
      • Table Global scleroderma calcium channel blockers market 2016-2021 ($ millions)
      • Table Drivers and challenges of calcium channel blockers
  • Geographical segmentation
    • Table Global scleroderma treatment market segmentation based on geography 2016 and 2021 (%)
    • Table Global scleroderma treatment market revenue by geography 2016-2021 ($ millions)
    • Scleroderma treatment market in Americas
      • Table Market scenario in Americas
      • Table Scleroderma treatment market in Americas 2016-2021 ($ millions)
    • Scleroderma treatment market in EMEA
      • Table Market scenario in EMEA
      • Table Scleroderma treatment market in EMEA 2016-2021 ($ millions)
    • Scleroderma treatment market in APAC
      • Table Market scenario in APAC
      • Table Scleroderma treatment market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Promising new projects in scleroderma studies
    • Market challenges
  • Market trends
    • Partnerships and strategic alliances
    • Introduction of stem cells in scleroderma treatment
    • Advent of novel therapies
      • Table Potential therapeutic targets involved in numerous studies for scleroderma
  • Vendor landscape
    • Competitive scenario
      • Table Strategic success factors of companies in global scleroderma treatment market
  • Key vendor analysis
    • AstraZeneca
      • Table AstraZeneca: Key highlights
      • Table AstraZeneca: Strength assessment
      • Table AstraZeneca: Strategy assessment
      • Table AstraZeneca: Opportunity assessment
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Key highlights
      • Table F. Hoffmann-La Roche: Strength assessment
      • Table F. Hoffmann-La Roche: Strategy assessment
      • Table F. Hoffmann-La Roche: Opportunity assessment
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Key highlights
      • Table GlaxoSmithKline: Strength assessment
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Pfizer
      • Table Pfizer: Key highlights
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report